谷歌浏览器插件
订阅小程序
在清言上使用

HERIZON: A Phase II Study of HER-Vaxx (IMU-131), a HER2targeting Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with HER2+advanced Stomach Cancer - Dose-dependent Anti-Cancer Antibodies Correlating with Improved Clinical Outcome

ANNALS OF ONCOLOGY(2023)

引用 0|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要